OCGN FY 2013 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$754M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8,000-69.2% YoY

Gross Profit

$8,000100.0% margin

Operating Income

-$17M-210562.5% margin

Net Income

-$26M-321400.0% margin

EPS (Diluted)

$-120.93

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$16M

Stock-Based Comp.

$158,000

Balance Sheet

Total Assets

$15M

Total Liabilities

$90M

Stockholders' Equity

-$76M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8,000	$26,000	-69.2%
Gross Profit	$8,000	$26,000	-69.2%
Operating Income	-$17M	-$15M	-12.5%
Net Income	-$26M	-$17M	-51.8%